DEEP EXPERIENCE. SHARED COMMITMENT.
"We take a private equity approach to a sector that’s traditionally been dominated by venture and early-stage growth firms. We'll work very closely with management to improve the operations of the business, update the product portfolio and revamp the commercial organization. We provide the support and resources our portfolio companies need to succeed.”
19
active portfolio companies
+
2000
employees worldwide
5
AP-II Investments to Date
9
successful exits
news
Nov 14, 2022
ACCELMED PARTNERS CLOSES $35 MILLION INVESTMENT IN SKNV
Helps Customized Rx Dermatology and Digital Health Company Accelerate Expansion of Product Offerings, Platform Technologies, and Operational Footprint to Enhance Practice Care
Nov 14, 2022
Accelmed announces its investment in VeranexVeranex brings together best-in-class expertise in product design and engineering, medical device evaluation, clinical development, data management, regulatory, and market access to deliver an integrated and comprehensive solution to the MedTech market, enabling its customers to efficiently move from concept to commercialization.
Sep 20, 2022
Veranex Expands European MedTech Capabilities With Acquisition of MedideeThe only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired Medidee, a top MedTech consultancy company headquartered in Lausanne, Switzerland.
Aug 31, 2022
MedMinder Expands Aging at Home Care with $35M InvestmentMedMinder, the leader in connected pharmacy care for polypharmacy and senior patients, announced today it has closed an additional $35 million in funding through a credit facility with SWK Holdings Corporation and additional investment from existing equity partner, Accelmed Partners.
Contact Us